• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Contineum Therapeutics, Inc. - Common stock (NQ: CTNM )

    20.06 -1.13 (-5.33%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 71,621
    Open 21.06
    Bid (Size) 17.67 (10)
    Ask (Size) 23.00 (1)
    Prev. Close 21.19
    Today's Range 20.00 - 21.23
    52wk Range 13.27 - 22.00
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Contineum Therapeutics Announces Publication of Encouraging Data in the Proceedings of the National Academy of Sciences on PIPE-307, Its M1 Receptor Selective Inhibitor, in Clinical Development for Relapse-Remitting Multiple Sclerosis
    From Contineum Therapeutics, Inc.
    Via Business Wire
    Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
    From Contineum Therapeutics, Inc.
    Via Business Wire

    Performance

    YTD
    +30.26%
    +30.26%
    1 Month
    -4.48%
    -4.48%
    3 Month
    +29.84%
    +29.84%
    6 Month
    +30.26%
    +30.26%
    1 Year
    +30.26%
    +30.26%

    More News

    Read More
    Contineum Therapeutics to Present at the 45th Annual Goldman Sachs Healthcare Conference
    From Contineum Therapeutics, Inc.
    Via Business Wire
    Contineum Therapeutics Announces Appointment of John Healy as General Counsel & Corporate Secretary
    From Contineum Therapeutics, Inc.
    Via Business Wire
    Contineum Therapeutics Announces Appointment of Troy Ignelzi to Board of Directors
    From Contineum Therapeutics, Inc.
    Via Business Wire
    Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    From Contineum Therapeutics, Inc.
    Via Business Wire
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.